Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer

PURPOSE: Gene expression profiling assays are frequently used to guide adjuvant chemotherapy decisions in hormone receptor–positive, lymph node–negative breast cancer. We hypothesized that the clinical value of these new tools would be more fully realized when appropriately integrated with high-qual...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Oncol
Päätekijät: Kim, Hyun-seok, Umbricht, Christopher B., Illei, Peter B., Cimino-Mathews, Ashley, Cho, Soonweng, Chowdhury, Nivedita, Figueroa-Magalhaes, Maria Cristina, Pesce, Catherine, Jeter, Stacie C., Mylander, Charles, Rosman, Martin, Tafra, Lorraine, Turner, Bradley M., Hicks, David G., Jensen, Tyler A., Miller, Dylan V., Armstrong, Deborah K., Connolly, Roisin M., Fetting, John H., Miller, Robert S., Park, Ben Ho, Stearns, Vered, Visvanathan, Kala, Wolff, Antonio C., Cope, Leslie
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2016
Aiheet:
ORIGINAL REPORTS
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455310/
https://ncbi.nlm.nih.gov/pubmed/27998227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.67.7195
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia